1. Home
  2. FTEK vs SNY Comparison

FTEK vs SNY Comparison

Compare FTEK & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fuel Tech Inc.

FTEK

Fuel Tech Inc.

HOLD

Current Price

$1.26

Market Cap

38.1M

Sector

Industrials

ML Signal

HOLD

Logo Sanofi ADS

SNY

Sanofi ADS

HOLD

Current Price

$46.64

Market Cap

107.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTEK
SNY
Founded
1987
1994
Country
United States
France
Employees
N/A
74846
Industry
Pollution Control Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.1M
107.3B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
FTEK
SNY
Price
$1.26
$46.64
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$61.50
AVG Volume (30 Days)
191.8K
3.7M
Earning Date
03-03-2026
04-23-2026
Dividend Yield
N/A
3.47%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,467,000.00
N/A
Revenue This Year
$14.17
$3.01
Revenue Next Year
$11.62
$5.80
P/E Ratio
N/A
$6.14
Revenue Growth
N/A
N/A
52 Week Low
$0.93
$43.32
52 Week High
$3.64
$56.00

Technical Indicators

Market Signals
Indicator
FTEK
SNY
Relative Strength Index (RSI) 43.64 57.51
Support Level N/A $45.20
Resistance Level $1.49 $48.97
Average True Range (ATR) 0.06 0.76
MACD 0.01 0.31
Stochastic Oscillator 37.50 86.16

Price Performance

Historical Comparison
FTEK
SNY

About FTEK Fuel Tech Inc.

Fuel Tech Inc is a technology provider of boiler optimization, efficiency improvement, and air pollution reduction to utility and industrial customers. The company operates in two segments, Air Pollution Control and Fuel Chem. The Air Pollution Control technology segment includes technologies to reduce NOx emissions in flue gas from boilers, incinerators, furnaces, and other stationary combustion sources. The Fuel Chem technology segment uses chemical processes in combination with Computational Fluid Dynamics and Chemical Kinetics Modeling for boiler modeling for the control of slagging, fouling, corrosion, opacity and other sulfur trioxide-related issues in furnaces and boilers through the addition of chemicals into the furnace using TIFI Targeted In-Furnace Injection technology.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: